lupus Archives -

Merck takes on Lilly/Nektar in IL-2 with $1.85bn Pandion buy

https://pharmaphorum.com/news/merck-takes-on-lilly-nektar-in-il-2-with-1-85bn-pandion-buy/

GSK’s Benlysta claims first FDA okay for lupus kidney damage

https://pharmaphorum.com/news/gsks-benlysta-claims-first-fda-okay-for-lupus-kidney-damage/

PREDiCT: Autoimmune Disease Modeling Summit

https://pharmaphorum.com/events/predict-autoimmune-disease-modeling-summit/

AZ fleshes out positive trial of revitalised lupus drug anifrolumab

https://pharmaphorum.com/news/az-fleshes-out-positive-trial-of-revitalised-lupus-drug-anifrolumab/

Gilead says arthritis drug filgotinib fails in follow-up use trials

https://pharmaphorum.com/news/gilead-says-arthritis-drug-filgotinib-fails-in-follow-up-use-trials/

Could phase 3 trial win save AZ’s troubled Lupus drug?

https://pharmaphorum.com/news/could-phase-3-trial-win-save-azs-troubled-lupus-drug/

Roche’s Gazyva shows promise in Lupus nephritis trial

https://pharmaphorum.com/news/roches-gazyva-shows-promise-in-lupus-nephritis-trial/

FDA approves first treatment for children with lupus

https://pharmaphorum.com/news/fda-approves-first-treatment-children-lupus/

AZ’s lupus drug fails in late-stage trial

https://pharmaphorum.com/news/astrazeneca-anifrolumab-fails-trial/

Search